Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer[1][2].
Molecular Weight:
563.64
Purity:
99.66
CAS Number:
[143664-11-3]
Formula:
C34H33N3O5
Target:
BCRP,P-glycoprotein
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted